Quipt Home Medical Corp

Quipt Home Medical Corp. engages in the provision of in-home monitoring and disease management services including end-to-end respiratory solutions. Its services include sleep apnea and pap treatment, home ventilation, equipment solutions, daily and ambulatory aides, power mobility, respiratory equipment rental, and oxygen therapy. The company was founded on March 5, 1993 and is headquartered in Wilder, KY.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Quipt Home Medical Corp. engages in the provision of in-home monitoring and disease management services including end-to-end respiratory solutions. Its services include sleep apnea and pap treatment, home ventilation, equipment solutions, daily and ambulatory aides, power mobility, respiratory equipment rental, and oxygen therapy. The company was founded on March 5, 1997 and is headquartered in Wilder, KY.

Calendar 2022 Run-Rate Revenue Surpasses $130 Million Calendar 2022 Run-Rate Revenue Surpasses $130 Million

Quipt Adds $13 Million in Annualized Revenue, $1.6 Million in Net Income, Anticipated $2.9 Million of Adjusted EBITDA Post Integration and 15,000 New Active Patients With Acquisition of Indiana Based Company

CINCINNATI, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, announces that, further to its December 16, 2021 news release, its application for a management cease trade order (the “MCTO”) under National Policy 12-203 – Management Cease ‎Trade Orders (“NP 12-203”) has been approved by the British Columbia Securities Commission (“BCSC”). The MCTO does ‎not affect the ability of investors (other than management) to trade in the securities of the Company.‎

Quipt Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update

CINCINNATI, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is very pleased to announce record preliminary financial results for the fourth quarter of 2021, ending September 30, 2021 as well as a business update with respect to recent announcements.

Quipt Home Medical Announces Record Preliminary Fourth Quarter 2021 Results and Provides a Business Update

CINCINNATI, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, announces that it anticipates that it will miss the deadline of December 29, 2021 to file the Company's audited annual financial statements and management discussion & analysis for the financial years ended September 30, 2021 and 2020, and the CEO and CFO certificates, all as required by National Instrument 51-102 and National Instrument 52-109 (collectively, the “Documents”).

Quipt Announces That It Anticipates a Temporary Delay in the Filing of Financial Statements and Application for Management Cease Trade Order

QIPT shares started 2021 strong, but likely dipped due to multiple headwinds, including a warrant overhang and possible tax-loss selling. Two recent announcements should bode well for the stock as we enter the new year, with the distinct possibility that QIPT will be added to the Russell 2000 in June.

Quipt's Recent Announcements Signal Good Times Ahead

Target Would Serve as Quipt's Entrance Into Comprehensive Respiratory Care Within the Long-Term Care Setting, and Provide Cross Selling Opportunity

Quipt Announces Execution of LOI to Acquire Leader in Comprehensive Respiratory Care Within the Long-Term Care Setting With Approximately $14 Million in Annualized Revenue and $1 Million in Net Income

Quipt Home Medical ( QIPT , Financial) is a high-quality medical equipment supply company based in North America that delivers in-house monitoring equipment, oxygen therapy, daily and ambulatory aids, sleep apnea treatment, home ventilation and respiratory equipment rentals. Previously, I wrote a detailed introductory piece on the Kentucky-based medical devices company, which provides initial equipment supply and implementation to thousands of patients every year through its subscription-based revenue model.

Quipt Home Medical: A Hot Acquisition Spree

Acquisition Provides Quipt Expansionary Opportunity Into Additional Long Term Care Facilities, Hospital Systems and Other Medical Facilities Acquisition Provides Quipt Expansionary Opportunity Into Additional Long Term Care Facilities, Hospital Systems and Other Medical Facilities

Quipt Announces Strategic Acquisition of Biomedical Services Company in the Southeastern United States

Target Is Located and Services a Major Metro Hub in the Midwestern United States and Would Add Over 15,000 Active Patients Target Is Located and Services a Major Metro Hub in the Midwestern United States and Would Add Over 15,000 Active Patients

Quipt Announces Execution of LOI To Acquire Leading Respiratory Supplier With Approximately $13 Million in Annualized Revenue and $1.6 Million in Net Income and Provides Outlook for 2022 Calendar End Run-rate of $180-$190 Million With $38-$43 Million in A

$2.5 Million in Annualized Revenues, 25% Projected Adjusted EBITDA Margin Post Integration, and Adds Over 3,700 Active Patients

Quipt Continues National Expansion With Closing of Strategic Acquisition in Central Illinois and Ongoing Business Momentum as Respiratory Equipment Demand Remains Elevated Into Fiscal Q1 2022

Boston Scientific

QIPT vs. BSX: Which Stock Is the Better Value Option?

QIPT vs. BSX: Which Stock Should Value Investors Buy Now?

Advanced Semiconductor Engineering

PAE Inc

Zeta Global Holdings Corp

While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

5 Red-Hot Buy-Rated Stocks Priced Under $10 With Huge Upside

150,000 current active patients 19,000 referring physicians

Quipt Reaches 150,000 Active Patients With Closing of Strategic Acquisition in Mississippi and Announces Hiring of EVP of Operations

CINCINNATI, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company” or “Quipt”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced that the Quipt Team, together with Greg Crawford, Chairman and CEO, will ring the Nasdaq Opening Bell on Thursday, September 2, 2021, in celebration of Quipt's listing on Nasdaq on May 27, 2021. The ceremony will begin at approximately 9:15 am (ET) and can be viewed live at https://www.nasdaq.com/marketsite/bell-ringing-ceremony.

Quipt Home Medical to Ring Nasdaq Opening Bell on September 2, 2021

QIPT shares have recovered from their warrant overhang lows, but still have plenty of room to run, with a triple possible within 3 years.

Quipt Home Medical: Acquisitions And Earnings Breathe Life Back Into Shares

Quipt Home Medical (NASDAQ: QIPT) is a U.S.-based leader in the home medical equipment industry focusing on end-to-end respiratory care and providing in-home monitoring medical equipment, supplies and services to patients.  Quipt offers a variety of medical products and services, including daily and ambulatory aides, oxygen therapy, sleep apnea treatment, home ventilation and respiratory equipment rental.

Quipt Home Medical Acquires Missouri-Based Medical Equipment Company with $5.5 Million Annual Revenue

Quipt Home Medical Corp. (QIPT) CEO Greg Crawford on Q3 2021 Results - Earnings Call Transcript

Posts Revenue Growth of 41% and Adjusted Ebitda Growth of 21%

Quipt Home Medical Reports Record Third Quarter Fiscal 2021 Financial Results

Image Provided By Pixabay Analysts raised their price target for QIPT from around $2 to $3 at the start of 2021 to between $9 and $13 per share after Quipt Home Medical (NASDAQ: QIPT) exceeded quarterly earnings expectations yet again. The company behind the innovative in-home monitoring and disease management platform has reported consistent and strong growth over the past year.

Analysts Raise QIPT Price Target Amid Low Debt Burden, Strong Growth

$5.5 Million in Annualized Revenues, 20% Adjusted EBITDA Margin Post Integration Expected, 1,500 Unique Referring Physicians Added $5.5 Million in Annualized Revenues, 20% Adjusted EBITDA Margin Post Integration Expected, 1,500 Unique Referring Physicians Added

Quipt Adds 15,000 Active Patients With Closing of Strategic Acquisition Within a Metro Hub of Missouri

CINCINNATI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, will report its third quarter 2021 financial results after markets close on Monday, August 23, 2021.

Quipt Home Medical Corp. to Report Third Quarter 2021 Financial Results on August 23, 2021

Webcasted Presentation to Be Held Wednesday, August 11th Webcasted Presentation to Be Held Wednesday, August 11th

Quipt Home Medical to Participate at the 41st Annual Canaccord Growth Conference on August 10th - 12th

National Expansion Continues With Entrance Into California, Missouri, Arkansas and Mississippi; $5.5 Million in Annualized Revenues, 10% Adjusted EBITDA Margin Prior to Integration, and Increases Active Patient Count by More Than 10,000 National Expansion Continues With Entrance Into California, Missouri, Arkansas and Mississippi; $5.5 Million in Annualized Revenues, 10% Adjusted EBITDA Margin Prior to Integration, and Increases Active Patient Count by More Than 10,000

Quipt Enters Four New States With Closings of Strategic Acquisitions

New York, New York--(Newsfile Corp. - July 12, 2021) - Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ: QIPT) (TSXV: QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, was recently the focus of an article by leading financial news website and publisher, SmallCapsDaily. The article describes Quipt Home Medical's emergence as a leader within the home medical device industry. As a result of the pandemic, home...

SmallCapsDaily: QIPT Emerges As a Leader Within the New Generation of Medical Device Suppliers

The medical device industry is gradually witnessing an increase in demand due to the ageing population in North America, and home medical equipment is no exception to this rule. There are a number of interesting companies within this domain that could be long-term candidates, but I have my eyes on Quipt Home Medical Corp ( QIPT , Financial).

News for Quipt Home Medical Corp Stock (QIPT)